133 related articles for article (PubMed ID: 1700486)
1. Autism: review of neurochemical investigation.
Cook EH
Synapse; 1990; 6(3):292-308. PubMed ID: 1700486
[TBL] [Abstract][Full Text] [Related]
2. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
Baghdadli A; Gonnier V; Aussilloux C
Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
[TBL] [Abstract][Full Text] [Related]
3. Monoamines in autism: an update of neurochemical research on a pervasive developmental disorder.
Anderson GM
Med Biol; 1987; 65(2-3):67-74. PubMed ID: 3309489
[TBL] [Abstract][Full Text] [Related]
4. [Disorders of catecholamine metabolism in infantile autism. Comparative study of 22 autistic children].
Ferrari P; Bursztejn C; Dreux C; Braconnier A; Zarifian E; Lancrenon S; Fermanian J
Encephale; 1989; 15(2):255-62. PubMed ID: 2752959
[TBL] [Abstract][Full Text] [Related]
5. [Metabolism of serotonin in autism in children].
Bursztejn C; Ferrari P; Dreux C; Braconnier A; Lancrenon S
Encephale; 1988; 14(6):413-9. PubMed ID: 3068046
[TBL] [Abstract][Full Text] [Related]
6. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT
J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
[TBL] [Abstract][Full Text] [Related]
7. Further studies in the developmental hyperserotonemia model (DHS) of autism: social, behavioral and peptide changes.
McNamara IM; Borella AW; Bialowas LA; Whitaker-Azmitia PM
Brain Res; 2008 Jan; 1189():203-14. PubMed ID: 18062943
[TBL] [Abstract][Full Text] [Related]
8. Urinary excretion of 5-hydroxyindoleacetic acid, serotonin and 6-sulphatoxymelatonin in normoserotonemic and hyperserotonemic autistic individuals.
Mulder EJ; Anderson GM; Kemperman RF; Oosterloo-Duinkerken A; Minderaa RB; Kema IP
Neuropsychobiology; 2010; 61(1):27-32. PubMed ID: 19923863
[TBL] [Abstract][Full Text] [Related]
9. Clinical neurochemistry of autism and associated disorders.
Young JG; Kavanagh ME; Anderson GM; Shaywitz BA; Cohen DJ
J Autism Dev Disord; 1982 Jun; 12(2):147-65. PubMed ID: 6184361
[TBL] [Abstract][Full Text] [Related]
10. Ontogeny of brain and blood serotonin levels in 5-HT receptor knockout mice: potential relevance to the neurobiology of autism.
Janusonis S; Anderson GM; Shifrovich I; Rakic P
J Neurochem; 2006 Nov; 99(3):1019-31. PubMed ID: 16981893
[TBL] [Abstract][Full Text] [Related]
11. [Opiate hypothesis in infantile autism? Therapeutic trials with naltrexone].
Leboyer M; Bouvard MP; Launay JM; Recasens C; Plumet MH; Waller-Perotte D; Tabuteau F; Bondoux D; Dugas M
Encephale; 1993; 19(2):95-102. PubMed ID: 8275903
[TBL] [Abstract][Full Text] [Related]
12. Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism.
Coutinho AM; Oliveira G; Morgadinho T; Fesel C; Macedo TR; Bento C; Marques C; Ataíde A; Miguel T; Borges L; Vicente AM
Mol Psychiatry; 2004 Mar; 9(3):264-71. PubMed ID: 15094787
[TBL] [Abstract][Full Text] [Related]
13. Hyperserotonemia in autism: the potential role of 5HT-related gene variants.
Hranilović D; Novak R; Babić M; Novokmet M; Bujas-Petković Z; Jernej B
Coll Antropol; 2008 Jan; 32 Suppl 1():75-80. PubMed ID: 18405062
[TBL] [Abstract][Full Text] [Related]
14. Serotonergic paradoxes of autism replicated in a simple mathematical model.
Janusonis S
Med Hypotheses; 2005; 64(4):742-50. PubMed ID: 15694691
[TBL] [Abstract][Full Text] [Related]
15. Statistical distribution of blood serotonin as a predictor of early autistic brain abnormalities.
Janusonis S
Theor Biol Med Model; 2005 Jul; 2():27. PubMed ID: 16029508
[TBL] [Abstract][Full Text] [Related]
16. Neurochemical correlates of autistic disorder: a review of the literature.
Lam KS; Aman MG; Arnold LE
Res Dev Disabil; 2006; 27(3):254-89. PubMed ID: 16002261
[TBL] [Abstract][Full Text] [Related]
17. Serotonin metabolism and other biochemical parameters in infantile autism. A controlled study of 22 autistic children.
Launay JM; Ferrari P; Haimart M; Bursztejn C; Tabuteau F; Braconnier A; Pasques-Bondoux D; Luong C; Dreux C
Neuropsychobiology; 1988; 20(1):1-11. PubMed ID: 2466221
[TBL] [Abstract][Full Text] [Related]
18. Brain growth trajectories in mouse strains with central and peripheral serotonin differences: relevance to autism models.
Flood ZC; Engel DL; Simon CC; Negherbon KR; Murphy LJ; Tamavimok W; Anderson GM; Janušonis S
Neuroscience; 2012 May; 210():286-95. PubMed ID: 22450231
[TBL] [Abstract][Full Text] [Related]
19. [Monoamine and monoamine enzyme abnormalities in childhood autism].
Garnier C; Barthelemy C; Garreau B; Jouve J; Muh JP; Lelord G
Encephale; 1983; 9(3):201-62. PubMed ID: 6317336
[TBL] [Abstract][Full Text] [Related]
20. Altered chemical metabolites in the amygdala-hippocampus region contribute to autistic symptoms of autism spectrum disorders.
Endo T; Shioiri T; Kitamura H; Kimura T; Endo S; Masuzawa N; Someya T
Biol Psychiatry; 2007 Nov; 62(9):1030-7. PubMed ID: 17631869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
